Levemir

Type: Product
Name: Levemir
First reported Jul 22 2014 - Updated 39 mins ago - 1 reports

Cost-conscious payers are eyeing higher prices on diabetes drugs

A time-honored technique for boosting drug sales is simple: Raise prices. Lately, plenty of drugmakers pressed by patent-cliff losses have done just that. But some notable price hikes on diabetes drugs may be backfiring with payers. With diabetes costs ... [Published FiercePharma - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets

The “Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to ... [Published Bio-Medicine - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 22 2014 - 1 reports

Sevenoaks Chronicle published Mike Conway rains in Toronto

Comments (0)MIKE Conway earned his second Verizon Indycar Series victory of the season by holding off Tony Kanaan over a three-lap sprint to the finish in the second race of the Honda Indy Toronto double-header on Sunday.Conway, driving the No 20 Fuzzy's ... [Published Sevenoaks Chronicle - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Levemir® FlexTouch® Insulin Pen

A Pen with No Push Extenstion Novo Nordisk®, makers of Levemir®, - aka insulin Detemir - have just come out with a new flexpen device that allows you to inject up to 80 units of Levemir® in one injection without having to use a push down extension feature. ... [Published About - Jul 21 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

AntriaBio Presents Vast Upside With Disruptive Once-Weekly Insulin

Summary AntriaBio's once-weekly insulin injection is in early-stage development, but as the examples used have shown, potentially disruptive drugs candidates have warranted rich valuations even at early stages. The AB101 weekly insulin injection is ... [Published Seeking Alpha - Jul 16 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Type 2

Found myself in ketoacidosis after being off Orals at least 1mo. Took 40u Novolog, 120u Levemir-it was available. My blood glucose is 534, extremely restless, urinating every hour, sickening sweet smell all around me, tried bathing. Plan to recheck ... [Published HealthBoards - Jul 10 2014]
First reported Jun 30 2014 - Updated Jul 01 2014 - 1 reports

Worldwide Human Insulin Market 2014-2018 Research Report Now Available at ReportsnReports.com

ReportsnReports.com offers Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) ... [Published PRWeb - Jun 30 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

Human Insulin Market worth $42 Billion by 2018

DALLAS, June 27, 2014 /PRNewswire/ --According to the new market research report, "Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand ... [Published PR Newswire: General Business - Jun 27 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Novo Nordisk A/S : Announces U.S. Launch of New Insulin Device Levemir® FlexTouch®

By a News Reporter-Staff News Editor at Life Science Weekly -- Novo Nordisk , a world leader in diabetes care, announced the availability of its newest prefilled insulin delivery device Levemir(®) FlexTouch(®) (insulin detemir [rDNA origin] injection) ... [Published 4 Traders - Jun 26 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 8 reports

Novo Nordisk new insulin pen to stimulate U.S. demand

Levemir FlexTouch--Courtesy of Novo NordiskIt's not often that Americans opt for a more difficult option over a simple one. But when it comes to insulin to treat the growing ranks of those with diabetes, U.S. patients are much more likely to use a vial ... [Published FierceMedicalDevices - Jun 19 2014]
First reported Jun 16 2014 - Updated Jun 17 2014 - 1 reports

Sanofi's Diabetes Portfolio in Focus at American Diabetes Association Sessions

Sanofi ’s ( SNY ) diabetes segment, accounting for more than 20% of the company’s total revenues, is currently in focus at the ongoing scientific sessions of the American Diabetes Association (:ADA).At ADA, Sanofi presented data from an 8-week, randomized, ... [Published Yahoo! Finance - Jun 16 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 1 reports

Novo Nordisk Raises Insulin Prices As Demand Grows

It affects an estimated 380 million people worldwide, 27 million in the U.S. But for drug companies, it's an opportunity.Denmark'sNovo Nordisk ( NVO ) is a leading player in the market. Unlike chief rivalsEli Lilly ( LLY ) andSanofi ( SNY ), which target ... [Published Nasdaq - Jun 13 2014]

Quotes

Browse 112 market data tables and 43 figures spread through 250 pages and in-depth TOC on "Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2019"
"The tyre temperatures came in really fast and that's what you need in those types of conditions, so I could just control it and not have to push too hard and enjoy those last few laps,” said Conway, who had not recorded a top-ten finish since his win at Long Beach on April 13."
According to a new market report published by Transparency Market Research "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" the global biological drugs market is estimated at USD 161,056.5 million in 2014 and is expected to grow at a CAGR of 10...
CEO Nevan Elam ran Nektar Therapeutics " (NASDAQ: NKTR ) Pulmonary division, responsible for getting the first inhaled mealtime replacement therapy, Exubera, market approval. Though Exubera was considered a failure, Nektar's pulmonary unit was sold to Novartis for $115M."

More Content

All (41) | News (28) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
Cost-conscious payers are eyeing higher prices ... [Published FiercePharma - Jul 22 2014]
Human Insulin Market Worth $42 Billion by 2019 ... [Published Bio-Medicine - Jul 22 2014]
Human Insulin Market Worth $42 Billion by 2019 ... [Published PRWeb - Jul 22 2014]
5 More Possible Partners For MannKind's Afrezza... [Published Seeking Alpha - Jul 21 2014]
Sevenoaks Chronicle published Mike Conway rains... [Published Sevenoaks Chronicle - Jul 21 2014]
Levemir® FlexTouch® Insulin Pen [Published About - Jul 21 2014]
Global Biological Drugs Market is Expected to R... [Published Wall Street Business Network - Jul 16 2014]
AntriaBio Presents Vast Upside With Disruptive ... [Published Seeking Alpha - Jul 16 2014]
Type 2 [Published HealthBoards - Jul 10 2014]
ReportsnReports.com: 2018 Human Insulin Industr... [Published BusinessWeek - Jul 01 2014]
MannKind: What The Afrezza Label Really Says [Published Seeking Alpha - Jun 30 2014]
Worldwide Human Insulin Market 2014-2018 Resear... [Published PRWeb - Jun 30 2014]
Human Insulin Market worth $42 Billion by 2018 [Published Good Day Sacramento - Jun 27 2014]
Human Insulin Market worth $42 Billion by 2018 [Published PR Newswire: General Business - Jun 27 2014]
Novo Nordisk A/S : Announces U.S. Launch of New... [Published 4 Traders - Jun 26 2014]
How to Beat the 3 Big Mistakes That Worsen Diab... [Published Bottom Line Publications - Jun 20 2014]
Novo Nordisk new insulin pen to stimulate U.S. ... [Published FierceMedicalDevices - Jun 19 2014]
Novo Nordisk launches prefilled insulin device [Published Drug Store News - Jun 19 2014]
Novo Nordisk Announces U.S. Launch of New Insul... [Published PharmaceuticalProcessing - Jun 19 2014]
New Insulin Delivery Device Launched in U.S. [Published P&T Community - Jun 19 2014]
Novo Nordisk launch new insulin device Levemir ... [Published Pharma Letter - Jun 19 2014]
Novo Nordisk Announces U.S. Launch of New Insul... [Published CEOWorld Magazine - Jun 19 2014]
Novo Nordisk Announces U.S. Launch of New Insul... [Published PR Newswire: Policy & Public Interest - Jun 19 2014]
Novo says switching to Tresiba could reduce NHS... [Published PMLive - Jun 19 2014]
Novo Nordisk announces availability of Levemir ... [Published Medical Devices Business Review - Jun 19 2014]
FDA to Pharma: Forget About Tweets! But You Can... [Published Pharma Marketing Blog - Jun 18 2014]
June 19 - Diabetes Medication [Published WMDT ABC-47 - Jun 18 2014]
Sanofi's Diabetes Portfolio in Focus at America... [Published Yahoo! Finance - Jun 16 2014]
Are Investors Overestimating The Market For Man... [Published Seeking Alpha - Jun 16 2014]
Novo Nordisk Raises Insulin Prices As Demand Grows [Published Nasdaq - Jun 13 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Type 2 [Published HealthBoards - Jul 10 2014]
Found myself in ketoacidosis after being off Orals at least 1mo. Took 40u Novolog, 120u Levemir-it was available. My blood glucose is 534, extremely restless, urinating every hour, sickening sweet smell all around me, tried bathing. Plan to recheck ...
Human Insulin Market worth $42 Billion by 2018 [Published PR Newswire: General Business - Jun 27 2014]
DALLAS, June 27, 2014 /PRNewswire/ --According to the new market research report, "Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand ...
Novo Nordisk Announces U.S. Launch of New Insul... [Published PR Newswire: Policy & Public Interest - Jun 19 2014]
PLAINSBORO, N.J., June 19, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir® FlexTouch® (insulin detemir [rDNA origin] injection) in the United ...
FDA to Pharma: Forget About Tweets! But You Can... [Published Pharma Marketing Blog - Jun 18 2014]
FDA has just released two guidance documents that finally address major issues discussed at the November 2009 public hearing:How to present both benefit and risk information within a “promotion” of their FDA-regulated medical products on electronic/digital ...
Pharma: Your Brand Celebrity Spokespersons Are ... [Published Pharma Marketing Blog - May 29 2014]
A survey developed by WP Engine and fielded by TNS found that nearly ALL consumers (96%) do NOT want to see stories about how celebrities use a company’s products (see " Majority of Americans Want Original Content Directly from Brands -- Not Stories ...
1 2

Press Releases

sort by: Date | Relevance
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - May 01 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - May 01 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Advertising News - Jan 30 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.